• Technical Guide to Angiotensin I/II (1-5) Peptide Use in RAS

  2026-04-25

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of blood pressure regulation and aldosterone release within renin-angiotensin system (RAS) research. Its use is limited to cardiovascular and renal workflows focused on peptide hormone vasoconstriction or angiotensin signaling, and is not suitable for off-target or unrelated peptide signaling studies.

• Benzyl-activated Streptavidin Magnetic Beads: Optimized Work

  2026-04-24

  Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) from APExBIO streamline biotinylated molecule capture, delivering high specificity and flexibility across protein, nucleic acid, and immunoprecipitation assays. This guide translates recent research and real-world scenarios into actionable protocols, troubleshooting strategies, and advanced use-cases for bench scientists.

• RNASEH1-AS1 as an Oncogenic lncRNA and Biomarker in HCC

  2026-04-24

  This study provides a comprehensive characterization of RNASEH1-AS1, a long non-coding RNA, as a prognostic and diagnostic biomarker in hepatocellular carcinoma (HCC). Through integrative bioinformatics, molecular experiments, and mechanistic studies, the paper establishes RNASEH1-AS1’s role in HCC progression and its interaction with DKC1, informing future biomarker and therapeutic strategies.

• SM-102: Enhancing mRNA Vaccine Delivery via Lipid Nanopartic

  2026-04-23

  SM-102, a high-purity synthetic ionizable lipid, is pivotal for constructing lipid nanoparticles in mRNA vaccine delivery systems. This article details practical workflows, experimental variables, and troubleshooting strategies, translating recent machine learning-driven advances and peer-reviewed evidence into actionable laboratory protocols.

• Thiazovivin (A5506): Technical Guide for ROCK Inhibition Pro

  2026-04-23

  Thiazovivin is a well-characterized ROCK inhibitor that addresses major challenges in stem cell workflows, specifically improving the survival of human embryonic stem cells after dissociation and enhancing the efficiency of fibroblast reprogramming to iPSCs. It is not suitable for diagnostic or therapeutic use and should be applied strictly within research environments following rigorous protocol controls.

• JNK-IN-7: Selective JNK Inhibitor for Targeted Apoptosis Stu

  2026-04-22

  JNK-IN-7, a highly selective JNK inhibitor from APExBIO, empowers researchers to dissect c-Jun phosphorylation and apoptosis with nanomolar precision. This article translates cutting-edge findings and protocol strategies into actionable workflows for MAPK pathway and innate immune signaling research.

• Asunaprevir (BMS-650032): Optimizing HCV Protease Inhibition

  2026-04-22

  Asunaprevir (BMS-650032) delivers robust, pan-genotypic HCV protease inhibition, empowering researchers to model antiviral responses across diverse cellular systems. This article details advanced protocol enhancements, troubleshooting strategies, and data-backed insights for maximizing assay fidelity and scientific impact using APExBIO’s trusted Asunaprevir.

• Sulfo-Cy3 NHS Ester: Hydrophilic Fluorescent Dye for Robust

  2026-04-21

  Sulfo-Cy3 NHS Ester stands apart for its unmatched water solubility and minimized quenching, enabling high-efficiency fluorescent labeling of challenging proteins and peptides. Advanced vascular biology and cell signaling applications benefit from its workflow flexibility, ease of use, and reliable performance.

• CPI-613 in Tumor Immunometabolism: Beyond Chemoresistance

  2026-04-21

  Explore how CPI-613, a first-in-class mitochondrial metabolism inhibitor, uniquely modulates tumor immunometabolism and macrophage function. This article uncovers advanced applications for CPI-613 in cancer research, highlighting new insights from recent literature.

• RNA Pol II Inhibition Triggers Apoptosis Independent of Tran

  2026-04-20

  Harper et al. reveal that cell death following RNA polymerase II (Pol II) inhibition is not due to passive mRNA decay but to an active signaling cascade initiated by the loss of hypophosphorylated Pol IIA. This fundamental insight shifts understanding of regulated apoptosis in cancer models and informs the design of targeted pathway experiments.

• Neuroligin 1 Proteolysis Drives Social Memory Maintenance Me

  2026-04-20

  This study reveals that proteolytic processing of Neuroligin 1 (NLG1), triggered by social interaction, is essential for maintaining short-term social memory in mice. The findings connect extracellular protease activity, intracellular signaling, and synaptic plasticity, advancing our understanding of memory mechanisms relevant to neuropsychiatric disorders.

• Geneticin (G-418 Sulfate): Precision Selection and Antiviral

  2026-04-19

  Explore Geneticin (G-418 Sulfate) as a next-generation selection antibiotic and antiviral tool. Learn how its mechanistic and assay-specific nuances empower advanced genetic engineering and virology research, with new insights beyond current literature.

• CLK4 Deficiency Drives Cardiac Hypertrophy via NEXN Phosphor

  2026-04-18

  This study identifies CDC-like kinase 4 (CLK4) as a critical regulator of cardiac hypertrophy through its effect on phosphorylation of nexilin (NEXN). Loss of CLK4 promotes pathological heart growth and dysfunction, highlighting protein phosphorylation as a therapeutic target in heart failure.

• Influenza Hemagglutinin (HA) Peptide: Precision Tag for Tran

  2026-04-17

  This thought-leadership article explores the Influenza Hemagglutinin (HA) Peptide as a pivotal enabler for translational researchers seeking mechanistic clarity and workflow acceleration in protein interaction and exosome biogenesis studies. Integrating mechanistic insights from recent literature, advanced protocol guidance, and a critical appraisal of the competitive landscape, the article positions APExBIO’s HA tag peptide as a uniquely validated, high-purity solution. Emphasis is placed on evidence-based best practices, reproducibility, and the evolving frontier of exosome research.

• Dorsomorphin (Compound C): Precision AMPK & BMP Pathway Cont

  2026-04-16

  Dorsomorphin (Compound C) empowers researchers with selective, ATP-competitive inhibition of AMPK and robust modulation of BMP/Smad signaling. This article details optimized workflows, troubleshooting tactics, and advanced applications, with actionable guidance for reproducible metabolic and differentiation assays using APExBIO’s trusted reagent.

16936 records 1/1130 page Next 12345 下5页 Last page